市場調査レポート

商品コード

1347826

鼻咽頭ぬぐい液市場- 成長、将来展望、競合分析、2023年～2031年

Nasopharyngeal Swabs Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日: 2023年08月30日
発行: Acute Market Reports
ページ情報: 英文 115 Pages
納期: 即日から翌営業日

価格

PDF (Single User License)

USD 4,500 660,690円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 6,500 954,330円

レポートPDFを10名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 9,000 1,321,380円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

鼻咽頭ぬぐい液市場は、特にCOVID-19パンデミック時の診断検査需要の増加に牽引され、2023年から2031年の予測期間中にCAGR 2.5%で成長する見込みです。鼻咽頭ぬぐい液は呼吸器検体の採取に広く使用されており、インフルエンザ、呼吸器合胞体ウイルス（RSV）、COVID-19の原因ウイルスであるSARS-CoV-2などの感染症の検出を可能にしています。市場の成長に寄与している主な要因の1つは、病気の早期発見の重要性に対するヘルスケア専門家や一般市民の意識の高まりです。鼻咽頭ぬぐい液は、非侵襲的で信頼性の高い方法で呼吸器検体を採取できるため、診断検査に好んで使用されています。さらに、ポイントオブケア検査施設の普及が鼻咽頭ぬぐい液の需要をさらに押し上げています。市場の収益は、主にパンデミック時のCOVID-19検査に対する前例のない需要により、大幅に急増しました。世界中の政府やヘルスケア機関が診断検査インフラに多額の投資を行ったため、鼻咽頭ぬぐい液の採用が急増しました。さらに、継続的な研究開発活動により、患者の快適性とサンプル採取効率を高める革新的なスワブデザインが導入され、市場の成長をさらに促進しています。しかし、市場に課題がないわけではないです。医療機器に対する厳しい規制要件や、地域によって異なる償還政策が鼻咽頭ぬぐい液の成長を阻害する可能性があります。さらに、唾液ベースの検査などの代替検体採取方法の出現は、市場拡大の潜在的な脅威となる可能性があります。

COVID-19パンデミック時の診断検査需要の増加

COVID-19パンデミックは鼻咽頭ぬぐい液市場の大きな促進要因となっています。ウイルスを特定し、蔓延を抑制するための広範な診断検査が必要となり、鼻咽頭ぬぐい液の需要が急増しました。世界中の政府やヘルスケア機関が検査インフラに多額の投資を行い、市場の成長に貢献しました。パンデミックの最中、空前の需要により鼻咽頭ぬぐい液が不足した国が多数報告されました。例えば、2020年初頭には米国が供給不足に直面し、政府は検査施設へのスワブの増産と配布を増やす措置を講じた。他の地域からも同様の報告があり、パンデミック時の鼻咽頭ぬぐい液の需要急増が浮き彫りになっています。

患者の快適性と検体採取効率を高める綿棒デザインの進歩

ヘルスケア業界における継続的な研究開発努力により、上咽頭スワブのデザインは大幅に改善されました。これらの技術革新は、サンプル採取中の患者の快適性を高め、処置の侵襲性を低減し、サンプル採取効率を改善することに重点を置いています。医学雑誌に掲載された研究では、綿棒のデザインにおける様々な進歩が報告されています。その中には、サンプル採取時に患者に不快感を与えない、柔軟で柔らかく、より小さなサイズの綿棒の開発が含まれています。研究論文はまた、正確な診断検査に必要なサンプルを十分に採取するための新しいスワブ・デザインの有効性を強調しており、スワブ技術の継続的な改良の重要性を強調しています。

病気の早期発見とポイントオブケア検査施設に対する意識の高まり

病気の早期発見の重要性に対するヘルスケア専門家や一般市民の意識の高まりが、鼻咽頭ぬぐい液の採用を後押ししています。ポイントオブケア検査施設が広く利用できるようになり、個人が迅速に検査を受け、迅速な結果を受け取ることが容易になっています。公衆衛生キャンペーン、メディア報道、教育イニシアティブは、病気の早期発見の重要性を強調しています。その結果、人々は診断検査を受けたがるようになり、多くの場合、鼻咽頭ぬぐい液を含む診断検査を受けるようになっています。さらに、診療所、薬局、コミュニティ・センターにおけるポイント・オブ・ケア検査施設の設置により、検査がより身近で便利になり、鼻咽頭ぬぐい液の需要にさらに貢献しています。

医療機器に対する厳しい規制要件

鼻咽頭ぬぐい液市場は、スワブを含む医療機器に課される厳しい規制要件により、大きな抑制要因に直面しています。各地域の規制当局は、綿棒の市場参入を許可する前に、厳格な試験、安全性評価、品質管理措置を義務付けています。このような要件は、しばしば承認までの期間を長くし、メーカーにとってはコスト増につながります。例えば、米国食品医薬品局（FDA）は、スワブ製造業者に対し、製品を販売する前に市販前通知プロセス（510（k））を遵守するか、市販前承認（PMA）を取得するよう求めています。同様に、欧州連合（EU）のCEマーキング・プロセスは、医療機器に対する適合性評価と必須健康安全要件への適合を必要とします。こうした厳しい規制のハードルは、製品の発売を遅らせたり、中小メーカーの鼻咽頭ぬぐい液市場への参入を阻害したりして、市場全体の成長に影響を与える可能性があります。その結果、企業は規制ガイドラインを確実に遵守するために多大な時間とリソースを投資しなければならず、イノベーションを妨げ、市場拡大を制限する可能性があります。評判の高い医学雑誌に掲載された調査論文や記事では、医療機器メーカーが鼻咽頭ぬぐい液の規制要件を満たすために直面する課題について論じています。これらの報告書は、規制当局から承認を得るために必要な複雑なプロセスや膨大な文書について詳述しています。さらに、ケーススタディでは、規制上の厳しい要求により、鼻咽頭ぬぐい液の市場導入の遅れやハードルに直面した事例を紹介しています。

フォームチップ綿棒は予測期間中にビジネスチャンスをもたらす

市場で入手可能なさまざまな種類の鼻咽頭ぬぐい液の中で、先端発泡綿棒は2023年から2031年の予測期間中に最も高いCAGRを示すと予想されます。フォームチップ綿棒は、サンプル採取における優れた性能と患者の快適性により人気を集めています。柔らかく柔軟なフォーム素材は、サンプル採取時に鼻腔に不快感や傷害を与えるリスクを最小限に抑え、ヘルスケア専門家と患者の両方にとって好ましいものとなっています。さらに、先端が泡状の綿棒は、正確な診断検査のために十分なサンプルを採取する効率が高いことが実証されており、COVID-19を含むさまざまな呼吸器感染症での採用が増加しています。その結果、COVID-19の大流行時に先端が尖った綿棒の需要が大幅に急増し、収益の著しい伸びに貢献しました。一方、不織布綿棒のCAGRと収益は比較的低いです。不織布綿棒は広く使用され、入手も容易であるが、先端が泡状の綿棒に比べ、使い心地や効率が劣ると思われがちです。不織布製綿棒よりも先端の泡状の綿棒が好まれることは、鼻咽頭ぬぐい液市場における採用率や収益が高いことからも明らかです。最後に、「その他」のカテゴリーには、フォームチップや不織布以外の様々なタイプの鼻咽頭ぬぐい液が含まれるが、市場シェアに占める割合は小さいです。このセグメントはニッチな選択肢を提供する一方で、フォームチップ綿棒の優れた性能と受容性に対抗する課題に直面しています。全体として、先端が泡状の綿棒が鼻咽頭ぬぐい液市場の明確なトップランナーとして浮上しており、その卓越した効率性、患者の快適性、COVID-19パンデミック時の需要増加により、最高のCAGRを経験し、最高の収益を生み出しています。

病院が引き続き主要エンドユーザー

鼻咽頭ぬぐい液市場のさまざまなエンドユーザーセグメントの中で、病院は2023年から2031年の予測期間中に最高のCAGRを示し、2022年の収益が期待されています。病院は、呼吸器感染症の診断と治療に重要な役割を担っているため、鼻咽頭ぬぐい液の主要な消費者です。COVID-19のような感染症の急増に伴い、鼻咽頭ぬぐい液に対する病院の需要は急増し、高収益に大きく貢献しています。さらに、病院には確立されたヘルスケア・インフラと検査室があるため、効率的で大規模な検査が可能であり、鼻咽頭ぬぐい液の需要をさらに押し上げています。診療所も重要な消費者ではあるが、CAGRと収益は比較的低いです。診療所では定期的に診断検査が行われているが、病院と比較して検査量が少ない可能性があります。さらに、唾液ベースの検査など別の検体採取方法を選択する診療所もあり、このセグメントにおける鼻咽頭ぬぐい液の成長に影響を与えています。学術・研究機関も重要なエンドユーザーセグメントであり、科学研究や臨床研究への関与を通じて鼻咽頭ぬぐい液市場に貢献しています。研究機関は、病院や診療所ほどの収益は上げられないかもしれませんが、様々な調査や試験で鼻咽頭ぬぐい液の安定した需要があるため、安定した市場シェアを確保しています。最後に、老人ホーム、在宅ヘルスケア、産業施設などを含む「その他」のカテゴリーは、病院、クリニック、研究機関に比べて市場シェアは小さいです。市場規模は小さいもの、このセグメントは依然として市場全体の収益に貢献しており、これは鼻咽頭ぬぐい液が多様な環境で汎用性と幅広い適用性を持つことを反映しています。結論として、鼻咽頭ぬぐい液市場では病院が最も高いCAGRと売上高を記録し、支配的なエンドユーザーセグメントとして際立っています。これは、疾病診断における重要な役割と、市場セグメンテーションの流行時に需要が高まったことが背景にあります。

APACは依然として世界のリーダー

北米は、2023年から2031年の予測期間中、CAGRが最も高い地域として浮上しました。同地域の強固なヘルスケアインフラ、先進診断技術の広範な導入、政府の積極的な取り組みが鼻咽頭ぬぐい液の需要を促進しています。COVID-19の発生は診断検査の必要性をさらに高め、この地域のCAGRの高さに大きく貢献しています。さらに、北米にはスワブの生産と流通に積極的に関与する主要な市場プレーヤーが複数存在し、市場の成長をさらに促進しています。一方、アジア太平洋地域は、2022年の鼻咽頭ぬぐい液市場において最も売上比率の高い地域です。この地域、特に中国やインドのような国々では人口が多いため、診断検査に対する大きな需要があり、鼻咽頭ぬぐい液の採用を後押ししています。さらに、病気の早期発見の重要性に対する意識の高まりと呼吸器感染症の有病率の増加が、アジア太平洋地域の市場成長を後押ししています。また、この地域には多数の現地メーカーが存在するため、鼻咽頭ぬぐい液の安定供給が確保されているという利点もあります。欧州およびラテンアメリカや中東などのその他の地域も、医療費の増加、疾病負担の増加、高度な診断技術の採用が鼻咽頭ぬぐい液市場の顕著な成長をもたらしています。

市場競争は予測期間中に激化へ

鼻咽頭ぬぐい液市場の主要企業としては、Thermo Fisher Scientific, Inc.、Becton, Dickinson and Company（旧C. R. Bard, Inc.）、Medical Wire &Equipment（MWE）、Titan Biotech Ltd.、COPAN Diagnostics, Inc.、Miraclean Technology Co.Ltd.、Puritan Medical Products、YOCON Biology、Trinity Biotech、VIRCELL S.L.、Quidel Corporationなどが挙げられます。これらの企業は強い存在感と市場への貢献で知られています。これらの企業は競争力を維持するために、綿棒のデザインや素材の継続的な革新、世界市場への展開と流通の効率化、戦略的提携や買収、厳しい規制要件の遵守など、さまざまな主要戦略を採用しています。また、積極的なマーケティングや教育イニシアティブも、これらの企業がブランドの認知度を高め、市場全体を拡大するのに役立っています。製品に焦点を当てた戦略に加え、主要企業は積極的なマーケティングや教育イニシアティブにも積極的に取り組んでいます。診断検査の重要性や疾患の早期発見における鼻咽頭ぬぐい液の役割を強調する啓発キャンペーンは、ブランドの認知度を高め、市場全体の拡大に寄与します。競争優位性を維持するため、これらの企業は厳しい規制要件の遵守を優先しています。規制当局から必要な認証や承認を得るための投資は、製品の安全性と品質を保証します。これは、患者の安全に対するコミットメントを示すだけでなく、医療従事者やエンドユーザーからの信頼を築くことにもなります。

市場概要
鼻咽頭ぬぐい液市場：タイプ別 2021-2031
鼻咽頭ぬぐい液市場：用途別 2021-2031
鼻咽頭ぬぐい液市場：エンドユーザー別 2021-2031
鼻咽頭ぬぐい液市場：地域別 2021-2031
- 英国と欧州連合
  - 英国
  - ドイツ
  - スペイン
  - イタリア
  - フランス
  - その他欧州地域

第10章アジア太平洋の鼻咽頭ぬぐい液市場 2021-2031

市場概要
鼻咽頭ぬぐい液市場：タイプ別 2021-2031
鼻咽頭ぬぐい液市場：用途別 2021-2031
鼻咽頭ぬぐい液市場：エンドユーザー別 2021-2031
鼻咽頭ぬぐい液市場：地域別 2021-2031
- アジア太平洋
  - 中国
  - 日本
  - インド
  - オーストラリア
  - 韓国
  - その他アジア太平洋地域

第11章ラテンアメリカの鼻咽頭ぬぐい液市場 2021-2031

市場概要
鼻咽頭ぬぐい液市場：タイプ別 2021-2031
鼻咽頭ぬぐい液市場：用途別 2021-2031
鼻咽頭ぬぐい液市場：エンドユーザー別 2021-2031
鼻咽頭ぬぐい液市場：地域別 2021-2031
- ラテンアメリカ
  - ブラジル
  - メキシコ
  - その他ラテンアメリカ地域

第12章中東・アフリカの鼻咽頭ぬぐい液市場 2021-2031

市場概要
鼻咽頭ぬぐい液市場：タイプ別 2021-2031
鼻咽頭ぬぐい液市場：用途別 2021-2031
鼻咽頭ぬぐい液市場：エンドユーザー別 2021-2031
鼻咽頭ぬぐい液市場：地域別 2021-2031
- 中東・アフリカ
  - GCC
  - アフリカ
  - その他中東・アフリカ地域

第13章企業プロファイル

Thermo Fisher Scientific Inc.
Becton Dickinson and Company（formerly C. R. Bard Inc.）
Medical Wire & Equipment（MWE）
Titan Biotech Ltd.
COPAN Diagnostics Inc.
Miraclean Technology Co. Ltd.
Puritan Medical Products
YOCON Biology
Trinity Biotech
VIRCELL S.L
Quidel Corporation
その他の主要企業

図表

List of Tables

TABLE 1 Global Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 2 Global Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 3 Global Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 4 North America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 5 North America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 6 North America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 7 U.S. Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 8 U.S. Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 9 U.S. Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 10 Canada Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 11 Canada Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 12 Canada Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 13 Rest of North America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 14 Rest of North America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 15 Rest of North America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 16 UK and European Union Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 17 UK and European Union Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 18 UK and European Union Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 19 UK Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 20 UK Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 21 UK Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 22 Germany Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 23 Germany Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 24 Germany Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 25 Spain Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 26 Spain Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 27 Spain Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 28 Italy Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 29 Italy Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 30 Italy Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 31 France Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 32 France Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 33 France Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 34 Rest of Europe Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 35 Rest of Europe Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 36 Rest of Europe Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 37 Asia Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 38 Asia Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 39 Asia Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 40 China Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 41 China Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 42 China Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 43 Japan Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 44 Japan Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 45 Japan Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 46 India Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 47 India Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 48 India Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 49 Australia Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 50 Australia Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 51 Australia Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 52 South Korea Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 53 South Korea Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 54 South Korea Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 55 Latin America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 56 Latin America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 57 Latin America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 58 Brazil Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 59 Brazil Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 60 Brazil Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 61 Mexico Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 62 Mexico Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 63 Mexico Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 64 Rest of Latin America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 65 Rest of Latin America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 66 Rest of Latin America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 67 Middle East and Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 68 Middle East and Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 69 Middle East and Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 70 GCC Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 71 GCC Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 72 GCC Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 73 Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 74 Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 75 Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
TABLE 76 Rest of Middle East and Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
TABLE 77 Rest of Middle East and Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
TABLE 78 Rest of Middle East and Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)

List of Figures

FIG. 1 Global Nasopharyngeal Swabs Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Nasopharyngeal Swabs Market: Quality Assurance
FIG. 5 Global Nasopharyngeal Swabs Market, By Type, 2022
FIG. 6 Global Nasopharyngeal Swabs Market, By Application, 2022
FIG. 7 Global Nasopharyngeal Swabs Market, By End-user, 2022
FIG. 8 Global Nasopharyngeal Swabs Market, By Geography, 2022
FIG. 9 Market Geographical Opportunity Matrix - Global Nasopharyngeal Swabs Market, 2022

FIG. 10Market Positioning of Key Nasopharyngeal Swabs Market Players, 2022

FIG. 11Global Nasopharyngeal Swabs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

FIG. 12 Global Nasopharyngeal Swabs Market, By Type, 2022 Vs 2031, %
FIG. 13 Global Nasopharyngeal Swabs Market, By Application, 2022 Vs 2031, %
FIG. 14 Global Nasopharyngeal Swabs Market, By End-user, 2022 Vs 2031, %
FIG. 15 U.S. Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 16 Canada Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 17 Rest of North America Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 18 UK Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 19 Germany Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 20 Spain Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 21 Italy Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 22 France Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 23 Rest of Europe Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 24 China Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 25 Japan Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 26 India Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 27 Australia Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 28 South Korea Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 29 Rest of Asia Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 30 Brazil Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 31 Mexico Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 32 Rest of Latin America Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 33 GCC Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 34 Africa Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
FIG. 35 Rest of Middle East and Africa Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031

Product Code: 139749-08-23

The nasopharyngeal swabs market is expected to grow at a CAGR of 2.5% during the forecast period of 2023 to 2031, driven by the increasing demand for diagnostic testing, particularly during the COVID-19 pandemic. nasopharyngeal swabs are widely used for the collection of respiratory specimens, enabling the detection of infectious diseases, including influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, the virus responsible for COVID-19. One of the key factors contributing to the market's growth is the rising awareness among healthcare professionals and the general public about the importance of early disease detection. nasopharyngeal swabs offer a non-invasive and reliable method to collect respiratory specimens, making them a preferred choice for diagnostic testing. Additionally, the widespread availability of point-of-care testing facilities has further boosted the demand for nasopharyngeal swabs. The market's revenue has witnessed a substantial surge, primarily due to the unprecedented demand for COVID-19 testing during the pandemic. Governments and healthcare organizations across the globe invested heavily in diagnostic testing infrastructure, leading to a surge in the adoption of nasopharyngeal swabs. Moreover, ongoing research and development activities have led to the introduction of innovative swab designs that enhance patient comfort and sample collection efficiency, further driving market growth. However, the market is not without its challenges. Stringent regulatory requirements for medical devices and variations in reimbursement policies across different regions can hinder the growth of nasopharyngeal swabs. Additionally, the emergence of alternative specimen collection methods, such as saliva-based testing, may pose a potential threat to the market's expansion.

Increased Demand for Diagnostic Testing During the COVID-19 Pandemic

The COVID-19 pandemic has been a significant driver of the nasopharyngeal swabs market. The need for widespread diagnostic testing to identify and control the spread of the virus led to a surge in demand for nasopharyngeal swabs. Governments and healthcare organizations worldwide invested heavily in testing infrastructure, contributing to the market's growth. During the pandemic, there were numerous reports of countries experiencing shortages of nasopharyngeal swabs due to unprecedented demand. For instance, in early 2020, the United States faced supply constraints, prompting the government to take measures to increase the production and distribution of swabs to testing facilities. Similar reports emerged from other regions, highlighting the surging demand for nasopharyngeal swabs during the pandemic.

Advancements in Swab Design for Enhanced Patient Comfort and Sample Collection Efficiency

The continuous research and development efforts in the healthcare industry have led to significant improvements in nasopharyngeal swab design. These innovations have focused on increasing patient comfort during sample collection, reducing the invasiveness of the procedure, and improving sample collection efficiency. Published studies in medical journals have reported on various advancements in swab design. These include the development of flexible, softer, and smaller-sized swabs that cause less discomfort to patients during sample collection. Research papers have also highlighted the efficacy of novel swab designs in collecting adequate samples for accurate diagnostic testing, reinforcing the importance of ongoing improvements in swab technology.

Growing Awareness of Early Disease Detection and Point-of-Care Testing Facilities

The increasing awareness among healthcare professionals and the general public about the importance of early disease detection has driven the adoption of nasopharyngeal swabs. Point-of-care testing facilities have become more widely available, making it easier for individuals to get tested quickly and receive prompt results. Public health campaigns, media coverage, and educational initiatives have emphasized the significance of early disease detection. As a result, people are more inclined to undergo diagnostic testing, which often involves nasopharyngeal swabs. Moreover, the establishment of point-of-care testing facilities in clinics, pharmacies, and community centers has made testing more accessible and convenient, further contributing to the demand for nasopharyngeal swabs.

Stringent Regulatory Requirements for Medical Devices

The nasopharyngeal swabs market faces a significant restraint due to the stringent regulatory requirements imposed on medical devices, including swabs. Regulatory authorities across different regions mandate rigorous testing, safety evaluations, and quality control measures before allowing swabs to enter the market. These requirements often lead to longer approval timelines and higher costs for manufacturers. For instance, the U.S. Food and Drug Administration (FDA) requires swab manufacturers to comply with the premarket notification process (510(k)) or obtain premarket approval (PMA) before marketing their products. Similarly, the European Union's CE marking process entails conformity assessments and compliance with essential health and safety requirements for medical devices. These stringent regulatory hurdles can delay product launches and inhibit smaller manufacturers from entering the nasopharyngeal swabs market, impacting overall market growth. As a result, companies must invest significant time and resources to ensure compliance with regulatory guidelines, potentially hindering innovation and restricting market expansion. Published research papers and articles in reputable medical journals discuss the challenges faced by medical device manufacturers in meeting regulatory requirements for nasopharyngeal swabs. These reports detail the complex processes and substantial documentation necessary for obtaining approvals from regulatory authorities. Additionally, case studies highlight instances where companies faced delays and hurdles in introducing nasopharyngeal swabs to the market due to stringent regulatory demands.

Foam-Tipped Swabs to Promise Opportunities During the Forecast Period

Among the different types of nasopharyngeal swabs available in the market, foam-tipped swabs are expected to exhibit the highest CAGR during the forecast period of 2023 to 2031. Foam-tipped swabs are gaining popularity due to their superior performance in sample collection and patient comfort. The soft and flexible foam material minimizes the risk of causing discomfort or injury to the nasal passage during sample collection, making them preferable for both healthcare professionals and patients. Moreover, foam-tipped swabs have demonstrated higher efficiency in collecting an adequate sample for accurate diagnostic testing, leading to increased adoption in various respiratory infections, including COVID-19. As a result, foam-tipped swabs have experienced a significant surge in demand during the COVID-19 pandemic, contributing to their remarkable revenue growth. Non-woven swabs, on the other hand, have shown a comparatively lower CAGR and revenue. Although non-woven swabs are widely used and readily available, they are often perceived to be less comfortable and efficient than foam-tipped swabs. The preference for foam-tipped swabs over non-woven swabs is evident from their higher adoption rates and revenue in the nasopharyngeal swabs market. Lastly, the "Others" category, which includes various types of nasopharyngeal swabs apart from foam-tipped and non-woven, accounts for a smaller portion of the market share. While this segment offers some niche options, it faces challenges in competing with the superior performance and acceptance of foam-tipped swabs. Overall, foam-tipped swabs have emerged as the clear frontrunner in the nasopharyngeal swabs market, experiencing the highest CAGR and generating the highest revenue due to their exceptional efficiency, patient comfort, and increased demand during the COVID-19 pandemic.

Hospitals Remain the Key End Users

Among the various end-user segments in the nasopharyngeal swabs market, hospitals are expected to exhibit the highest CAGR during the forecast period of 2023 to 2031 and revenue generated in 2022. Hospitals are the primary consumers of nasopharyngeal swabs due to their critical role in diagnosing and treating a wide range of respiratory infections. With the surge in infectious diseases like COVID-19, hospitals' demand for nasopharyngeal swabs has skyrocketed, contributing significantly to their high revenue generation. Moreover, hospitals have well-established healthcare infrastructure and laboratories, allowing for efficient and large-scale testing, further boosting the demand for nasopharyngeal swabs. Clinics, although also significant consumers have shown a comparatively lower CAGR and revenue. While clinics regularly perform diagnostic testing, they may have less capacity for testing volume compared to hospitals. Additionally, some clinics may opt for alternative specimen collection methods, such as saliva-based testing, impacting the growth of nasopharyngeal swabs in this segment. Academia & research institutes represent another important end-user segment, contributing to the nasopharyngeal swabs market through their involvement in scientific studies and clinical research. While research institutions may not generate as much revenue as hospitals and clinics, their consistent demand for nasopharyngeal swabs for various studies and trials ensures a stable market share. Lastly, the "Others" category, including settings like nursing homes, home healthcare, and industrial facilities, holds a smaller market share compared to hospitals, clinics, and research institutes. Despite its smaller size, this segment still contributes to the overall market revenue, reflecting the versatility and broad applicability of nasopharyngeal swabs across diverse settings. In conclusion, hospitals stand out as the dominant end-user segment in the nasopharyngeal swabs market, with the highest CAGR and revenue, driven by their crucial role in disease diagnosis and the heightened demand during the COVID-19 pandemic.

APAC remains the Global Leader

North America has emerged as the region with the highest CAGR during the forecast period of 2023 to 2031. The robust healthcare infrastructure, extensive adoption of advanced diagnostic technologies, and proactive government initiatives in the region have fueled the demand for nasopharyngeal swabs. The outbreak of COVID-19 further intensified the need for diagnostic testing, contributing significantly to the region's high CAGR. Additionally, North America houses several key market players actively involved in swab production and distribution, further driving market growth. On the other hand, Asia-Pacific held the distinction of being the region with the highest revenue percentage in the nasopharyngeal swabs market in 2022. The region's large population, especially in countries like China and India, has translated into a substantial demand for diagnostic testing, boosting the adoption of nasopharyngeal swabs. Furthermore, growing awareness of the importance of early disease detection and the increasing prevalence of respiratory infections have driven market growth in Asia-Pacific. The region also benefits from the presence of a significant number of local manufacturers, ensuring a steady supply of nasopharyngeal swabs. Europe and other regions, such as Latin America and the Middle East, have also experienced notable growth in the nasopharyngeal swabs market, driven by increasing healthcare expenditures, rising disease burden, and the adoption of advanced diagnostic technologies.

Market Competition to Intensify during the Forecast Period

Among the top players in the nasopharyngeal swabs market are Thermo Fisher Scientific, Inc., Becton, Dickinson and Company (formerly C. R. Bard, Inc.), Medical Wire & Equipment (MWE), Titan Biotech Ltd., COPAN Diagnostics, Inc., Miraclean Technology Co., Ltd., Puritan Medical Products, YOCON Biology, Trinity Biotech, VIRCELL S.L, and Quidel Corporation. These companies are known for their strong presence and contribution to the market. They employ various key strategies to stay competitive, including continuous innovation in swab designs and materials, global market reach and distribution efficiency, strategic partnerships and acquisitions, and compliance with stringent regulatory requirements. Proactive marketing and educational initiatives also help these companies increase their brand visibility and expand the overall market. In addition to product-focused strategies, top players actively engage in proactive marketing and educational initiatives. Awareness campaigns highlighting the importance of diagnostic testing and the role of nasopharyngeal swabs in early disease detection help increase brand visibility and contribute to overall market expansion. To maintain their competitive advantage, these companies prioritize compliance with stringent regulatory requirements. Investments in obtaining necessary certifications and approvals from regulatory authorities ensure the safety and quality of their products. This not only demonstrates their commitment to patient safety but also builds trust among healthcare professionals and end-users.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofNasopharyngeal Swabs market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Nasopharyngeal Swabs market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

Foam Tipped Swabs
Non-woven Swabs
Others

Application

Influenza
COVID-19
Respiratory Syncytial Virus
Bordetella Pertussis Infection
MRSA (Methicillin-resistant Staphylococcus aureus)
Others

End-user

Hospitals
Clinics
Academia & Research Institutes
Others

Region Segment (2021-2031; US$ Million)

North America
- U.S.
- Canada
- Rest of North America

UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Nasopharyngeal Swabs market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Nasopharyngeal Swabs market?

Which is the largest regional market for Nasopharyngeal Swabs market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Nasopharyngeal Swabs market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Nasopharyngeal Swabs market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Nasopharyngeal Swabs Market
2.2. Global Nasopharyngeal Swabs Market, By Type, 2022 (US$ Million)
2.3. Global Nasopharyngeal Swabs Market, By Application, 2022 (US$ Million)
2.4. Global Nasopharyngeal Swabs Market, By End-user, 2022 (US$ Million)
2.5. Global Nasopharyngeal Swabs Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022

3. Nasopharyngeal Swabs Market: Competitive Analysis

3.1. Market Positioning of Key Nasopharyngeal Swabs Market Vendors
3.2. Strategies Adopted by Nasopharyngeal Swabs Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Nasopharyngeal Swabs Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Nasopharyngeal Swabs Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Foam Tipped Swabs
- 5.3.2. Non-woven Swabs
- 5.3.3. Others

6. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Influenza
- 6.3.2. COVID-19
- 6.3.3. Respiratory Syncytial Virus
- 6.3.4. Bordetella Pertussis Infection
- 6.3.5. MRSA (Methicillin-resistant Staphylococcus aureus)
- 6.3.6. Others

7. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. Hospitals
- 7.3.2. Clinics
- 7.3.3. Academia & Research Institutes
- 7.3.4. Others

8. North America Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
8.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
8.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
8.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
  - 8.5.1.1. U.S.
    - 8.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 8.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 8.5.1.2. Canada
    - 8.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 8.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 8.5.1.3. Rest of North America
    - 8.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 8.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 8.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

9. UK and European Union Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
9.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
9.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
9.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
  - 9.5.1.1. UK
    - 9.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 9.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 9.5.1.2. Germany
    - 9.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 9.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 9.5.1.3. Spain
    - 9.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 9.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 9.5.1.4. Italy
    - 9.5.1.4.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 9.5.1.4.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.4.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 9.5.1.5. France
    - 9.5.1.5.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 9.5.1.5.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.5.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 9.5.1.6. Rest of Europe
    - 9.5.1.6.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 9.5.1.6.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 9.5.1.6.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

10. Asia Pacific Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
10.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
10.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
10.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
  - 10.5.1.1. China
    - 10.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 10.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 10.5.1.2. Japan
    - 10.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 10.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 10.5.1.3. India
    - 10.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 10.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 10.5.1.4. Australia
    - 10.5.1.4.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 10.5.1.4.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.4.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 10.5.1.5. South Korea
    - 10.5.1.5.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 10.5.1.5.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.5.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 10.5.1.6. Rest of Asia Pacific
    - 10.5.1.6.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 10.5.1.6.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 10.5.1.6.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

11. Latin America Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
11.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
11.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
11.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
  - 11.5.1.1. Brazil
    - 11.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 11.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 11.5.1.2. Mexico
    - 11.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 11.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 11.5.1.3. Rest of Latin America
    - 11.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 11.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 11.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

12. Middle East and Africa Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
12.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
12.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
12.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
  - 12.5.1.1. GCC
    - 12.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 12.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 12.5.1.2. Africa
    - 12.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 12.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  - 12.5.1.3. Rest of Middle East and Africa
    - 12.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
    - 12.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
    - 12.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

13. Company Profile

13.1. Thermo Fisher Scientific, Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
13.2. Becton, Dickinson and Company (formerly C. R. Bard, Inc.)
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
13.3. Medical Wire & Equipment (MWE)
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
13.4. Titan Biotech Ltd.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
13.5. COPAN Diagnostics, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
13.6. Miraclean Technology Co., Ltd.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
13.7. Puritan Medical Products
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
13.8. YOCON Biology
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
13.9. Trinity Biotech
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
13.10. VIRCELL S.L
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
13.11. Quidel Corporation
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
13.12. Other Notable Players
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives

鼻咽頭ぬぐい液市場- 成長、将来展望、競合分析、2023年～2031年

Nasopharyngeal Swabs Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

COVID-19パンデミック時の診断検査需要の増加

患者の快適性と検体採取効率を高める綿棒デザインの進歩

病気の早期発見とポイントオブケア検査施設に対する意識の高まり

医療機器に対する厳しい規制要件

フォームチップ綿棒は予測期間中にビジネスチャンスをもたらす

病院が引き続き主要エンドユーザー

APACは依然として世界のリーダー

市場競争は予測期間中に激化へ

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 鼻咽頭ぬぐい液市場：競合分析

第4章 鼻咽頭ぬぐい液市場：マクロ分析と市場力学

第5章 鼻咽頭ぬぐい液市場：タイプ別 2021-2031

第6章 鼻咽頭ぬぐい液市場：用途別 2021-2031

第7章 鼻咽頭ぬぐい液市場：エンドユーザー別 2021-2031

第8章 北米の鼻咽頭ぬぐい液市場 2021-2031

第9章 英国と欧州連合の鼻咽頭ぬぐい液市場 2021-2031

第10章 アジア太平洋の鼻咽頭ぬぐい液市場 2021-2031

第11章 ラテンアメリカの鼻咽頭ぬぐい液市場 2021-2031

第12章 中東・アフリカの鼻咽頭ぬぐい液市場 2021-2031

第13章 企業プロファイル